Skip to main content
GDU LC 2023 Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Thursday, May 4, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome
  • 8:15 AM – 9:00 AM ET
    Session 1: Birdseye View of the Current Treatment Landscape in Metastatic NSCLC without Actionable Mutations
  • 9:00 AM – 9:45 AM ET
    Session 2: Special Topic –EGFR Mutation
    Presenter: Heather Wakelee, MD – Stanford University
  • 9:45 AM – 10:45 AM ET
    A Treatment Option for Patients With Resectable NSCLC Dual Immunotherapy + Platinum-Based Chemotherapy for the Treatment of mNSCLC
  • 10:45 AM – 11:00 AM ET
    Exhibit Hall
  • 11:00 AM – 11:45 AM ET
    Session 3: EGFR: The Challenge of Primary and Secondary Resistance
  • 11:45 AM – 12:30 PM ET
    Session 4: Targeting ALK and ROS1: A Fusion Paradigm
    Presenter: Jyoti Patel, MD – Northwestern University
  • 12:30 PM – 1:30 PM ET
    The Evolving Role of Biomarkers in Advanced NSCLC - Speaker: Erin Bertino, MD
  • 1:30 PM – 2:15 PM ET
    Session 5: Targeting RET, NTRK, and NRG1
    Presenter: Marina Garassino, MD – University of Chicago
  • 2:15 PM – 3:00 PM ET
    Session 6: The Emergence of ADC: Will ADCs Alter the Therapeutic Landscape?
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall
  • 3:30 PM – 4:15 PM ET
    Session 7: The Primacy of Front-Line Checkpoint Inhibitors in NSCLC
    Presenter: Jyoti Patel, MD – Northwestern University
  • 4:15 PM – 5:15 PM ET
    KOL Round Table

    Presenter: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Helen J. Ross, MD – Rush University

    Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

    Presenter: Barbara Melosky, MD – Bc Cancer

    Presenter: Jyoti Patel, MD – Northwestern University

  • Friday, May 5, 2023
  • 8:45 AM – 9:00 AM ET
    Welcome
  • 9:00 AM – 9:45 AM ET
    Session 8: The Uncommon Tumors of the Thorax
  • 9:45 AM – 9:52 AM ET
    Session 9: Debate: How to Handle PD-L1 <1% - Chemo + IO
    Presenter: Marina Garassino, MD – University of Chicago
  • 9:52 AM – 9:59 AM ET
    Session 9: Debate: How to Handle PD-L1 <1% - IO Combos
    Presenter: Mary Fidler, MD – Rush University Medical Center
  • 9:59 AM – 10:06 AM ET
    Session 9: Debate: How to Handle PD-L1 1-49% - Chemo + IO
    Presenter: Marina Garassino, MD – University of Chicago
  • 10:06 AM – 10:13 AM ET
    Session 9: Debate: How to Handle PD-L1 1-49% - IO Only
    Presenter: Mary Fidler, MD – Rush University Medical Center
  • 10:13 AM – 10:30 AM ET
    Session 9: Debates: How to Handle PD-L1
    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
    Panelist: Marina Garassino, MD – University of Chicago
    Panelist: Mary Fidler, MD – Rush University Medical Center
  • 10:30 AM – 11:00 AM ET
    Exhibit Hall
  • 11:00 AM – 11:45 AM ET
    Session 10: Updates from Recent Meetings
  • 11:45 AM – 12:30 PM ET
    Session 11: Unique Immune Combinations with Checkpoint Inhibitors
    Presenter: Marina Garassino, MD – University of Chicago
  • 12:30 PM – 1:30 PM ET
    Lunch
  • 1:30 PM – 1:37 PM ET
    Session 12: Debate: How to Handle PD-L1 >50% - Chemo + IO
  • 1:37 PM – 1:44 PM ET
    Session 12: Debate: How to Handle PD-L1 >50% - IO Only
  • 1:44 PM – 1:51 PM ET
    Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
  • 1:51 PM – 1:58 PM ET
    Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - Adjuvant
  • 1:58 PM – 2:15 PM ET
    Session 12: Debates: How to Handle PD-L1 and Neoadjuvant vs Adjuvant Therapy
  • 2:15 PM – 3:00 PM ET
    Session 13: Advancing the Management of NSCLC: A Focus on Emerging Therapies
    Presenter: Ticiana Leal, MD – Emory University
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall
  • 3:30 PM – 4:15 PM ET
    Session 14: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLC
  • 4:15 PM – 5:00 PM ET
    Session 15: BRAF Mutations: Identifying and Addressing a Rare Oncogenic Driver
    Presenter: Edgardo Santos, MD – Genesis Care US
  • Saturday, May 6, 2023
  • 8:00 AM – 8:15 AM ET
    Welcome
  • 8:15 AM – 9:00 AM ET
    Session 16: The Road from DNA to Protein: Navigating the Minefield of Expression Amplification and Mutation
  • 9:00 AM – 9:45 AM ET
    Session 17: Liquid vs Tissue vs Both: The Holy Grail of Molecular Diagnostics
    Presenter: Mary Fidler, MD – Rush University Medical Center
  • 9:45 AM – 10:15 AM ET
    Exhibit Hall
  • 10:15 AM – 11:00 AM ET
    Session 18: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?
    Presenter: Daniel Morgensztern, MD – Washington University in St. Louis
  • 11:00 AM – 11:45 AM ET
    Session 19: The Power of Patient Advocacy
  • 11:45 AM – 12:30 PM ET
    Lunch
  • 12:30 PM – 12:45 PM ET
    Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - Yes
    Presenter: Vinai Gondi, MD – Northwestern Medicine West Region
  • 12:45 PM – 1:00 PM ET
    Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - No
  • 1:00 PM – 1:15 PM ET
    Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC
  • 1:15 PM – 1:45 PM ET
    Exhibit Hall
  • 1:45 PM – 2:30 PM ET
    Session 21: Finally Moving Forward in SCLC: The Pace of Progress is No Longer Glacial
    Presenter: Rebecca Heist, MD, MPH – Harvard Medical School, Massachusetts General Hospital
  • 2:30 PM – 3:15 PM ET
    Session 22: How to Handle PS2 Patients and the Elderly